Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
6 clinical trials · Sponsor
◉ Watch Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
| Record | Firm | Date |
|---|---|---|
| Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers (NCT03564158) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2018-05-01 |
| A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting (NCT03160040) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2017-10-11 |
Track Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) automatically
Every clearance here is in the API, with alerts when new ones post.